ODYSSEY – Type 2 Diabetes and High Cholesterol
Metabolic and Endocrine
Both males and females
18 years and above
We are testing the effect of an investigational drug on reducing cholesterol in patients with Type 2 Diabetes who may be at risk of developing coronary heart disease.
You may qualify for this trial is you:
- are over 18
- have Type 2 Diabetes
- have high cholesterol
Please note this trial is ethics approved, you will be medically supervised, and no costs are involved. Participation in this trial is voluntary.
If you are interested in learning more about this study, please contact our friendly research team.
Phone Number: 02 4963 2323 (take option 1)
Location: 41 Llewellyn St, Merewether, New South Wales, Australia
Approved By: Belberry Human Research Ethics
Clinical Trial Registry Link: